Finder makes money from featured partners, but editorial opinions are our own.

How to buy Cleo Diagnostics shares

Own Cleo Diagnostics shares in just a few minutes.

What we know so far

Offer price: $0.20
Proposed code: COV
Expected raise: $12,000,000
Expected listing: 22 August 2023
Buy shares

Cleo Diagnostics shares are now publicly available to purchase on the Australian Securities Exchange (ASX). Here's what we know about the IPO and how you can buy in.

Where to invest in the Cleo Diagnostics IPO

Cleo Diagnostics has listed on the ASX, so you can now buy shares over the stock market. To do that, you'll need to be signed up to a broker. Your cheapest option is to sign up to an online broker. Check out the steps below:

How to buy shares when Cleo Diagnostics lists

  1. Compare share trading platforms. To buy shares in an Australian-listed company, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Cleo Diagnostics. Find the share by name or ticker symbol: COV. You can also search for any other shares traded publicly on exchanges available within your chosen platform.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cleo Diagnostics reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At price of at you're buying the shares, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Cleo Diagnostics. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

What we know about the Cleo Diagnostics IPO

Cleo Diagnostics lodged its prospectus with the Australian Securities and Investments Commission (ASIC) to list on the ASX under the ticker symbol COV.

Taylor Collison Limited were appointed as lead managers with an expected raise of $12,000,000 at $0.20 per share. You can check out some of the key dates and figures in the table below:


Cleo Diagnostics IPO key numbers
Offer price $0.20
Dividend yield 0%
Total number of shares available under the offer 60,000,000
Proposed ASX code ASX: COV
Target market cap $25.7 million
Retail offer opens 8 July 2023
Retail offer closes 4 August 2023
Expected listing on ASX 22 August 2023
Expected dispatch of holding statements 17 August 2023
Source: Cleo Diagnostics prospectus

According to latest information available, retail investors (regular investors) have between 8 July 2023 and 4 August 2023 to participate in the Cleo Diagnostics IPO. After the retail offer close date, you'll need to wait until the stock is publicly available on the ASX to buy shares.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 6 of 6
Name Product Standard brokerage fee Inactivity fee Asset class
eToro
Finder AwardExclusive
eToro
$0
US$10 per month if there’s been no log-in for 12 months
ASX shares, Global shares, US shares, ETFs
CFD service. Capital at risk.
Finder exclusive: Get 12 months of investment tracking app Delta PRO for free when you fund your eToro account (T&Cs apply).
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
Finder Award
IG Share Trading
$8
$0
ASX shares, Global shares, US shares, UK shares, ETFs
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian and international shares, plus get access to 24-hour customer support.
Moomoo Share Trading
$3
$0
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get an additional 30 days on top of the regular brokerage-free period for new accounts. T&Cs apply.
Trade shares on the ASX, the US markets and buy ETFs with Moomoo. Plus join a community over 20 million investors.
CMC Invest
Finder Award
CMC Invest
$0
$0
ASX shares, Global shares, Options trading, US shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 35,000 products, including shares, crypto, ETFs and managed funds, with access to 15 major global and Australian stock exchanges. Plus, buy Aussie shares for $0 brokerage up to $1,000. (Limited to one buy order per stock per trading day).
Webull
$4.90
$0
ASX shares, Options trading, US shares, ETFs
Earn US$100 in cash vouchers when you fund your new account and maintain a minimum balance of US$2,000 by Dec 29 until March 31, 2024. Plus, earn up to 5.3% p.a. yield on your US cash account (T&Cs apply).
Trade ASX and US stocks and US options, plus gain access to inbuilt news platforms and educational resources. You can also start trading for less with fractional shares.
Tiger Brokers
Exclusive
Tiger Brokers
$5.50
$0
ASX shares, Global shares, US shares, ETFs
Finder exclusive: Get 10 brokerage-free trades for the US or ASX market for the first 180 days and US$50 fractional shares when you deposit at least US$500. Plus, all new customers get 1 free trade per month for the first 12 months (T&Cs apply).
Get one brokerage-free trade per month for the first 12 months for US or ASX markets. T&Cs apply.
loading

Balance sheet

Cleo Diagnostics was founded in 2022 and is in an early growth stage of development.

Company history

Cleo Diagnostics launched in 2022 and is headquartered in Melbourne, VIC.

How do I buy shares?

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades. Read the Product Disclosure Statement (PDS) and Target Market Determination (TMD) for the product on the provider's website.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and 6. Finder Group Privacy & Cookies Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site